Back to School: How biopharma can reboot drug development. Access exclusive analysis here

New products to watch

New products to watch

Company Product Indication Location
Acambis (LSE:ACM) ACAM2000 Prevent smallpox in subjects at high risk of exposure U.S.
Actelion (SWX:ATLN) Tracleer bosentan Reduce the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease EU
Alexion (NASDAQ:ALXN) Soliris eculizumab Paroxysmal nocturnal hemoglobinuria (PNH) U.S./EU
Amgen (NASDAQ:AMGN) Vectibix panitumumab EGFR-expressing metastatic colorectal cancer with wild-type K-ras (KRAS) genes after failure of standard

Read the full 698 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE